Advice
Following an abbreviated submission:
bimatoprost plus timolol preservative-free eye-drops (Ganfort® Unit Dose Preservative Free) are accepted for restricted use within NHS Scotland.
Indication under review: for the reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
SMC restriction: to use in patients who have proven sensitivity to preservatives.
SMC has previously accepted preserved bimatoprost plus timolol eye-drops for use in NHS Scotland. This preparation is more expensive than the equivalent multi-dose eye drop preparation with preservative.
Download detailed advice91KB (PDF)
Medicine details
- Medicine name:
- bimatoprost + timolol (Ganfort Unit Dose Preservative Free)
- SMC ID:
- 906/13
- Indication:
- For reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are sufficiently responsive to topical beta-blockers or prostaglandin analogues.
- Pharmaceutical company
- Allergan Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 07 October 2013